Stockerstrasse 47, 8002 Zürich, Switzerland
Cell Receptor Inc. has IP for improving results in oncological treatment by targeting upstream steps of growth signaling, not noticed in oncology yet. A well-tolerated affordable treatment of low toxicity! It will prevent metastasis in most cancers.www.nature.com/articles/d43747-021-00133-8
D36.ch is an innovative startup with a strong engineering DNA that empowers companies in healthcare and life sciences sectors throughout their digital transformation journeys. We offer a combination of products and services building a thriving digital healthcare technology landscape.
Founded in 1927, SICPA is an international company whose purpose is to Enable Trust, providing governments and authorities with unique solutions for secured authentication, identification and traceability, developping solutions that will further help authorities monitor and anticipate health risks.